Other Issues

Submission

Comments to NTP: Fluoride and Developmental Neurotoxicity

CHPA appreciates the opportunity to provide information relevant to the assessment of the evidence of the potential developmental neurotoxicity of fluoride.

Nov 24, 2015

Press Releases and Statements

CHPA Statement on House Energy & Commerce Committee Microbeads Legislation

CHPA President and CEO Scott Melville released the following statement today regarding this afternoon’s House Energy and Commerce (E&C) Committee passage of the Microbead-Free Waters Act of 2015.

Nov 18, 2015

Other Issues

Sustainability

Press Releases and Statements

CHPA Statement on Justice Department and Federal Partners Announcement of Enforcement Actions Against Illegal Products Sold as Supplements

Nov 17, 2015

Dietary Supplements

Other Issues

Good Manufacturing Practices

Video

Safe In-home Medicine Disposal

Follow three easy steps to safely dispose of expired medicines in your home.

Nov 16, 2015

OTC Medicines

Other Issues

Safe Storage

Take Back/Drug Disposal

New Jersey state house front view on a clear day

Press Releases and Statements

CHPA Applauds New Jersey Lawmakers for Age-18 Sales Law on Cough Medicine

CHPA expresses its gratitude to New Jersey's governor, senator, and assembly members for shepherding the bill through the legislature. CHPA has long supported state efforts to curb teen OTC cough medicine abuse.

Oct 14, 2015

OTC Medicines

DXM (dextromethorphan)

Other Issues

Ingredient Safety

Press Releases and Statements

CHPA Statement on Pediatrics Article Showing Decrease in Unsupervised Medication Exposures in Young Children

CHPA released the following statement in response to an article in Pediatrics, the official journal of the American Academy of Pediatrics, which reported a decline in emergency department visits for unsupervised medication exposures in young children.

Sep 8, 2015

Other Issues

Ingredient Safety

Safe Storage

Submission

Comments to USP: Packaging and Storage Requirements

CHPA is generally supportive of the revision proposal to update and clarify the Chapter. We would however request that the implementation be delayed for 24 months.

Jul 30, 2015

Other Issues

Packaging

Quality

Press Releases and Statements

CHPA Applauds House Introduction of DXM Abuse Prevention Act

CHPA is pleased to lend its strong support for the DXM Abuse Prevention Act of 2015 (H.R. 3250), introduced into the U.S. House of Representatives by U.S. Reps. Bill Johnson (R-OH) and Doris Matsui (D-CA).

Jul 28, 2015

OTC Medicines

DXM (dextromethorphan)

Other Issues

Ingredient Safety

Press Releases and Statements

CHPA Statement on FDA Drug Safety Communication on NSAIDs

The Consumer Healthcare Products Association today issued the following statement in response to the Food and Drug Administration’s Drug Safety Communication on non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs).

Jul 10, 2015